Endorsement of registration identifies practitioners with additional qualifications and specific expertise. The endorsement available for podiatry is scheduled medicines.
The Podiatry Board of Australia’s revised registration standard for endorsement for scheduled medicines and associated guidelines came into effect on 1 August 2018.
The revised registration standard and guidelines apply to podiatrists and podiatric surgeons applying for endorsement for scheduled medicines after 1 August 2018.
FAQ are available to help practitioners understand the new registration standard and guidelines.
Templates and a Prescribing Self Assessment Tool are also available to support practitioners using Pathway B of the registration standard to endorsement.
One of the requirements under Pathway B of the Board’s Registration standard: Endorsement for scheduled medicines (ESM registration standard) is the successful completion of 15 online case studies approved by the Board.
The Board has approved the following online case studies for the purpose of Pathway B of the ESM registration standard:
Recognising that there are practitioners working towards an endorsement under Pathway 2 of the previous registration standard when the new registration standard took effect on 1 August 2018, the Board has developed transitional arrangements.
The transitional arrangements allow these practitioners to continue under Pathway 2 or switch to Pathway B of the new registration standard.
If you are one of these practitioners, there are important timelines you must meet if you want to use the transitional arrangements.
Click on the tile below for information about the transitional arrangements.
Copies of documents provided in support of an application, or other purpose required by the National Law, must be certified as true copies of the original documents.
See Certifying Documents on the AHPRA web site.